Home Upload Photo Upload Videos Write a Blog Analytics Messaging Streaming Create Adverts Creators Program
Bebuzee Afghanistan Bebuzee Albania Bebuzee Algeria Bebuzee Andorra Bebuzee Angola Bebuzee Antigua and Barbuda Bebuzee Argentina Bebuzee Armenia Bebuzee Australia Bebuzee Austria Bebuzee Azerbaijan Bebuzee Bahamas Bebuzee Bahrain Bebuzee Bangladesh Bebuzee Barbados Bebuzee Belarus Bebuzee Belgium Bebuzee Belize Bebuzee Benin Bebuzee Bhutan Bebuzee Bolivia Bebuzee Bosnia and Herzegovina Bebuzee Botswana Bebuzee Brazil Bebuzee Brunei Bebuzee Bulgaria Bebuzee Burkina Faso Bebuzee Burundi Bebuzee Cabo Verde Bebuzee Cambodia Bebuzee Cameroon Bebuzee Canada Bebuzee Central African Republic Bebuzee Chad Bebuzee Chile Bebuzee China Bebuzee Colombia Bebuzee Comoros Bebuzee Costa Rica Bebuzee Côte d'Ivoire Bebuzee Croatia Bebuzee Cuba Bebuzee Cyprus Bebuzee Czech Republic Bebuzee Democratic Republic of the Congo Bebuzee Denmark Bebuzee Djibouti Bebuzee Dominica Bebuzee Dominican Republic Bebuzee Ecuador Bebuzee Egypt Bebuzee El Salvador Bebuzee Equatorial Guinea Bebuzee Eritrea Bebuzee Estonia Bebuzee Eswatini Bebuzee Ethiopia Bebuzee Fiji Bebuzee Finland Bebuzee France Bebuzee Gabon Bebuzee Gambia Bebuzee Georgia Bebuzee Germany Bebuzee Ghana Bebuzee Greece Bebuzee Grenada Bebuzee Guatemala Bebuzee Guinea Bebuzee Guinea-Bissau Bebuzee Guyana Bebuzee Haiti Bebuzee Honduras Bebuzee Hong Kong Bebuzee Hungary Bebuzee Iceland Bebuzee India Bebuzee Indonesia Bebuzee Iran Bebuzee Iraq Bebuzee Ireland Bebuzee Israel Bebuzee Italy Bebuzee Jamaica Bebuzee Japan Bebuzee Jordan Bebuzee Kazakhstan Bebuzee Kenya Bebuzee Kiribati Bebuzee Kuwait Bebuzee Kyrgyzstan Bebuzee Laos Bebuzee Latvia Bebuzee Lebanon Bebuzee Lesotho Bebuzee Liberia Bebuzee Libya Bebuzee Liechtenstein Bebuzee Lithuania Bebuzee Luxembourg Bebuzee Madagascar Bebuzee Malawi Bebuzee Malaysia Bebuzee Maldives Bebuzee Mali Bebuzee Malta Bebuzee Marshall Islands Bebuzee Mauritania Bebuzee Mauritius Bebuzee Mexico Bebuzee Micronesia Bebuzee Moldova Bebuzee Monaco Bebuzee Mongolia Bebuzee Montenegro Bebuzee Morocco Bebuzee Mozambique Bebuzee Myanmar Bebuzee Namibia Bebuzee Nauru Bebuzee Nepal Bebuzee Netherlands Bebuzee New Zealand Bebuzee Nicaragua Bebuzee Niger Bebuzee Nigeria Bebuzee North Korea Bebuzee North Macedonia Bebuzee Norway Bebuzee Oman Bebuzee Pakistan Bebuzee Palau Bebuzee Panama Bebuzee Papua New Guinea Bebuzee Paraguay Bebuzee Peru Bebuzee Philippines Bebuzee Poland Bebuzee Portugal Bebuzee Qatar Bebuzee Republic of the Congo Bebuzee Romania Bebuzee Russia Bebuzee Rwanda Bebuzee Saint Kitts and Nevis Bebuzee Saint Lucia Bebuzee Saint Vincent and the Grenadines Bebuzee Samoa Bebuzee San Marino Bebuzee São Tomé and Príncipe Bebuzee Saudi Arabia Bebuzee Senegal Bebuzee Serbia Bebuzee Seychelles Bebuzee Sierra Leone Bebuzee Singapore Bebuzee Slovakia Bebuzee Slovenia Bebuzee Solomon Islands Bebuzee Somalia Bebuzee South Africa Bebuzee South Korea Bebuzee South Sudan Bebuzee Spain Bebuzee Sri Lanka Bebuzee Sudan Bebuzee Suriname Bebuzee Sweden Bebuzee Switzerland Bebuzee Syria Bebuzee Taiwan Bebuzee Tajikistan Bebuzee Tanzania Bebuzee Thailand Bebuzee Timor-Leste Bebuzee Togo Bebuzee Tonga Bebuzee Trinidad and Tobago Bebuzee Tunisia Bebuzee Turkey Bebuzee Turkmenistan Bebuzee Tuvalu Bebuzee Uganda Bebuzee Ukraine Bebuzee United Arab Emirates Bebuzee United Kingdom Bebuzee Uruguay Bebuzee Uzbekistan Bebuzee Vanuatu Bebuzee Venezuela Bebuzee Vietnam Bebuzee World Wide Bebuzee Yemen Bebuzee Zambia Bebuzee Zimbabwe
Blog Image

High-Performance HPV IgG ELISA Kit for Accurate and Reliable HPV Antibody Detection

High-Performance HPV IgG ELISA Kit for Accurate and Reliable HPV Antibody Detection

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, announces the launch of its high-performance HPV IgG ELISA Kit for the sensitive and specific detection of antibodies to Human Papillomavirus Virus (HPV) in human serum or plasma. These products will improve customer experience, meet research needs and accelerate anti-HPV studies.

HPV is a member of the Papillomaviridae family that can infect humans. Like all papillomaviruses, HPV only forms productive infections in keratinocytes of the skin or mucous membranes. There are nearly 200 different strains of HPV, most of which are harmless and do not cause cancer. Fourteen of the high-risk HPV types (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) are known to cause cervical, vulvar, vaginal, penile, oropharyngeal, and anal cancers, and six others are suspected of causing cancer. HPV is also associated with an increased risk of cardiovascular disease.

Studies have shown that antibodies induced by different subtypes of HPV virus-like particles (VLPs) can inhibit infection by the corresponding HPV subtype. Specific antibody detection kits are required to assess whether vaccination is specifically inducing antibodies against that subtype but not others. Creative Diagnostics offers ELISA antibody detection kits for different HPV subtypes. These kits are supplied with microtiter plates precoated with VLP antigen. The VLPs are HPV L1 VLPs and electron microscopy has confirmed that they are complete virus-like particles, not just proteins. In addition, Western blot analysis has verified the purity of the VLPs, reducing the likelihood of false-positive results due to interference from contaminants.

Compared to ELISA kits coated with L1 protein and antibody detection kits coated with VLP L1, VLPs have conformational and type-specific epitopes similar to the actual viral structure. They bind better to antibodies produced in the natural immune state than L1 coated kits and have relatively better consistency of neutralization results, making them more suitable for relative comparisons between methods. In addition, Creative Diagnostics can customize kits coated with HPV L1+L2 pseudoviruses (PsV), which are even more consistent with the neutralization assay.

Creative Diagnostics is committed to providing high quality HPV ELISA Kits that meet research needs and facilitate anti-HPV research. For example, the HPV IgG ELISA Kit (Catalog # DEIA-F678S) can be used for the detection of HPV IgG class antibodies in human plasma and serum. This product is for research use only and is not intended for use in the diagnosis or follow-up of patients vaccinated with vaccines containing HPV antigens.

To learn more about Creative Diagnostics' portfolio of ELISA kits, reagents, and other research tools for various infectious diseases, please visit https://www.creative-diagnostics.com/HPV-IgG-EIA-Kit-139949-466.htm.

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. In addition to providing contract R&D and biologic manufacturing services for diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market, the company aims to continue to act as a trusted source for all researchers' assay development and manufacturing needs.

Previous Post

Hitting the Gym This Year? Here’s Your Must-Know Guide

Next Post

Novel Animal Models for Zika Virus Research

Comments